Vijaya Diagnostic Centre Limited has informed the Exchange regarding allotment of 171792 securities pursuant to Scheme of Arrangement/Amalgamation at its meeting held on January 08, 2026
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Smallcap 250 and 0.7 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vijaya Diagnostic Centre has allotted 1,71,792 equity shares of face value ₹1 each to eligible shareholders of Medinova Diagnostic Services Limited as part of the NCLT-approved Scheme of Amalgamation. The NCLT Hyderabad Bench had approved the merger on October 13, 2025, with the record date set as November 25, 2025. The Board approved this allotment via a circular resolution on January 8, 2026. The merger is now functionally complete, with the company's paid-up equity capital rising from ₹10,26,87,111 to ₹10,28,96,728. Fractional entitlements have been consolidated and handed to Catalyst Trusteeship Limited, which will sell them in the market and distribute net proceeds to fractional shareholders. A separate trust (VDCL Physical Shareholders Trust) has been set up to help Medinova shareholders who held shares in physical form convert them into dematerialised shares.
This is the final share-issuance step of the Medinova merger, so the dilution is already priced in from when the scheme was first announced. Shareholders of Vijaya face only a marginal increase in share count (~1.67% on equity capital value), so no significant price action is expected from the allotment itself. The key thing to watch now is how smoothly Medinova's business gets integrated into Vijaya's operations.